"It is subjecting your family to some very tough stuff," Dimon told David Novak on the "How Leaders Lead" podcast.

Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its target price decreased by equities research analysts at Leerink Partners from $980.00 to $862.00 in a research note issued on Tuesday.

Evercore ISI analyst Glenn Schorr maintained a Buy rating on JPMorgan Chase & Co. (JPM – Research Report) yesterday and set a price target ...

U.S. bank stocks such as JPMorgan Chase (JPM), Bank of America (BAC), and Goldman Sachs (GS) are marching higher on reports ...

When asked about the biggest challenge in 2025, volatility was the topic most mentioned by the traders, repeating a 2024 ...

Through the celebration of the achievements of Black talent, the awards advocate for an equitable representation of Black ...

In the face of employee backlash over JPMorgan Chase’s 5-day-a-week return to work mandate, company leaders are hoping their ...

NEW YORK (Reuters) - U.S. Treasury Secretary Scott Bessent's pledge to contain yields on 10-year Treasury notes met some ...

(Reuters) - A group of 17 Republican state attorneys general alleged that top U.S. asset managers, including BlackRock and ...

JPMorgan Chase’s new headquarters in Manhattan is designed to make the 5-day return-to-office mandate more enticing, with ...

In many ways, these have been tough days for Tesla. Falling sales. Squeezed profit margins. Proposed changes in US government policy that could cost the company billions.